Rat Syndecan-1 / SDC1 / CD138 Protein (His Tag)
  0 products, total $0.+86-400-890-9989      Login |  Register 中文한국어

Browse By Molecule:

Your Position: Home > Recombinant Protein > Human Cell Expressed > Rat Syndecan-1 / SDC1 / CD138 Protein (His Tag)

Rat Syndecan-1 / SDC1 / CD138 Protein (His Tag) PDF Download

Catalog   Size (Price) Quantity In Stock Operation

Protein Production & Purification Service | Recombinant Cytokines & Growth Factors

Syndecan 1 Protein Datasheet


SDC1 / Syndecan-1 / SYND1 Protein Price Inquiry ( Available Sizes )

SDC1 / Syndecan-1 / SYND1 Protein Product Information

Synonym : SDC1, Synd1
Protein Construction:

A DNA sequence encoding the rat SDC1 (P26260)(Met1-Lys253) was expressed with a polyhistidine tag at the C-terminus.

Source: Rat
Expression Host: Human Cells

SDC1 / Syndecan-1 / SYND1 Protein QC Testing

Purity: (76+20)% as determined by SDS-PAGE SDS-PAGE:

SDC1 / Syndecan-1 / SYND1 protein

Endotoxin: < 1.0 EU per μg of the protein as determined by the LAL method
Stability: Samples are stable for up to twelve months from date of receipt at -70℃
Predicted N terminal: Gln 23
Molecular Mass:

The recombinant rat SDC1 comprises 242 amino acids and predicts a molecular mass of 25.6 kDa. The apparent molecular mass of  the recombinant protein is approximately 47 and 49 kDa in SDS-PAGE under reducing conditions due to glycosylation.

Formulation: Lyophilized from sterile PBS, pH7.4.
  1. Normally 5 % - 8 % trehalose and mannitol are added as protectants before lyophilization. Specific concentrations are included in the hardcopy of COA.
  2. Please contact us for any concerns or special requirements.

SDC1 / Syndecan-1 / SYND1 Protein Usage Guide

Storage: Store it under sterile conditions at -70℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Reconstitution: A hardcopy of COA with reconstitution instruction is sent along with the products. Please refer to it for detailed information.

SDC1 / Syndecan-1 / SYND1 Protein Related Products & Topics

Related Areas:

Immunology>>Adhesion Molecule>>Extracellular Matrix Molecule>>Proteoglycan>>Syndecan-1/SDC1/CD138

Immunology>>Cluster of Differentiation>>Syndecan-1/SDC1/CD138


Molecule Species Description //For Detailed Info. and Price------CLICK! Cat. No
Syndecan-1/SDC1/CD138 Human Syndecan-1/SDC1/CD138 Protein, Recombinant 11429-H08H
Syndecan-1/SDC1/CD138 Mouse Syndecan-1/SDC1/CD138 Protein, Recombinant 50641-M08H
Syndecan-1/SDC1 Rat SDC1 / Syndecan-1 / SYND1 Protein, Recombinant 80344-R02H
Syndecan-1/SDC1 Rat SDC1 / Syndecan-1 / SYND1 Protein, Recombinant 80344-R08H


Molecule Application Description //For Detailed Info. and Price------CLICK! Cat. No
Human Syndecan-1 / SDC1 / CD138 IHC-P Syndecan-1 / SDC1 / CD138 Antibody (Antigen Affinity Purified) 11429-RP02
Mouse Syndecan-1 / SDC1 / CD138 WB, ELISA Syndecan-1 / SDC1 / CD138 Antibody (Antigen Affinity Purified) 50641-RP02

SDC1 / Syndecan-1 / SYND1 Protein Description

Syndecan-1, also known as SYND1, CD138 and SDC1, is a single-pass type I  membrane protein which belongs to the syndecan proteoglycan family. CD138 / Syndecan-1 is well known to be associated with cell proliferation, adhesion, and migration in various types of malignancies. It is a cell surface proteoglycan that bears both heparan sulfate and chondroitin sulfate and that links the cytoskeleton to the interstitial matrix. CD138 / Syndecan-1 is a cell-surface heparan sulfate proteoglycan expressed on most epithelial cells, and decreased CD138 expression is associated with increased invasive and metastatic potential in carcinomas. Within the hematopoietic system, CD138 is an excellent marker of plasmacytic differentiation. CD138 / Syndecan-1 is a cell surface proteoglycan that binds cells to the extracellular matrix and its expression is down-regulated in many cellular transformation models. CD138 / Syndecan-1 is a new simple non-invasive marker for predicting liver fibrosis in patients with chronic hepatitis C. The relevance of this marker in combination with other fibrosis markers should be explored. CD138 / Syndecan-1 might contribute to urothelial carcinoma cell survival and progression. It could be a new therapeutic target in urinary bladder cancer.


  1. O'Connell FP. et al., 2004, Am J Clin Pathol. 121 (2):254-63.
  2. Gkden N. et al., 2006, Appl Immunohistochem Mol Morphol. 14 (2): 173-7.
  3. Sun WP. et al., 2007, Cell Mol Immunol. 4 (3): 209-14.
  4. Zvibel I. et al., 2009, Liver Int. 29 (2): 208-12.
  5. Shimada K. et al., 2010, Cancer Sci. 101 (1): 155-60.